Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial

Sickle cell disease (SCD), an inherited blood disorder, is prevalent throughout sub-Saharan Africa. Approximately 240,000 children are born with SCD each year across the continent of Africa, and up to 70% of those infants born with sickle cell disease die before the age of five. 

University students in Nigeria willing to self test for HIV, cross-sectional study

A recent study co-authored by Dr. Muktar Aliyu, M.D., MPH, DrPH, professor of Health Policy and Medicine and associate director for research for VIGH, assessed the willingness of students at Bayero University in Nigeria to self-test for HIV. The World Health Organization (WHO) encourages the use of HIV self-testing, especially in areas such as West and Central Africa where 64% of people living with HIV are unaware of their status.

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique. One of the $1.5 million grants will establish The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program to build capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.

Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)

The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.

2020 Global Health Graduates

This year, 11 students graduated with a Master of Public Health (MPH) in Global Health, and seven received the Graduate Certificate in Global Health. Although official in-person Vanderbilt University graduations have been postponed to May 2021, the MPH Program held a virtual celebration for graduates and their families, friends, and mentors on May 8. The celebration included heartwarming presentations from students about their experiences in the Program and celebrated students who received awards. Congratulations, graduates!

Vanderbilt Lab Donation Supports Medical Education in Liberia

At the end of March, the Vanderbilt Institute for Global Health received a long-awaited message from Liberia – the 40-foot shipping container of medical books and other laboratory equipment donated by the Vanderbilt School of Medicine had survived it’s journey across the ocean and arrived at its final destination, the University of Liberia. The letter signaled the end of a nearly year-long donation effort at Vanderbilt and the beginning of new opportunities for current and future medical students in Liberia.

Team to test app for improving HIV care for new mothers in South Africa

South Africa has more HIV/AIDS patients than any other country and is home to the world’s largest antiretroviral program. According to the World Bank, as of 2018 the prevalence of HIV among South Africans ages 15 to 49 was 20.4%. Nearly one in three pregnant women attending antenatal care in South Africa is living with HIV. As South Africans with HIV move around the country, there is a risk they will disengage from the health care system or otherwise become lost to follow-up care.

Clinical Trials Workshop in Zambia Lead by VUMC and University of Zambia Draws Almost 200 Participants

The NIH-Fogarty supported UNZA-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP) continues a multi-decade training collaboration between the University of Zambia School of Medicine/University Teaching Hospital (UNZA/UTH) and the Vanderbilt Institute for Global Health (VIGH).